Donna A. James - 05 May 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: Director
Issuer ticker: BSX
Reported as of: 05 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 May 2022, 17:06:45 UTC
Prior SEC filing: 24 Nov 2021
Next SEC filing: 01 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact

Key filing fact

Donna A. James filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 06 May 2022.

Key facts

This page summarizes Donna A. James's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 May 2022, 17:06.

Change

Previous filing in this sequence was filed on 24 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +4,877
Change %: +21%
Price: $0.000000
Shares after: 28,124
Date: 05 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,877
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.

Footnote F3

Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC remarks

jamespoa.txt